Concert AI’s CancerLinQ initiative has received ASCO’s Recognized Quality Solution status—a recognition that positions the platform as a validated gateway for partnered oncology practices into ASCO’s flagship certification program.
UC Davis Health and UCLA are co-leading a newly funded national clinical trial to evaluate whether AI can help radiologists interpret screening mammograms more accurately. The goal is to improve breast cancer detection and reduce unnecessary callbacks and anxiety for patients.
